United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), sodium phosphate, dibasic, unspecified form (unii: gr686lba74) (sodium cation - unii:lyr4m0nh37), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37) - sodium chloride 7.44 mg in 1 ml - indications and usage:  bss plus is indicated for use as an intraocular irrigating solution during intraocular surgical procedures involving perfusion of the eye. contraindications:  there are no specific contraindications to the use of bss plus; however, contraindications for the surgical procedure during which bss plus is to be used should be strictly adhered to. geriatric use:  no overall differences in safety or effectiveness have been observed between elderly and younger patients. reconstitution instructions directions: use aseptic technique - remove the blue flip-off seal from the bss plus® part i (480 ml) bottle. remove the blue flip-off seal from the bss plus part ii (20 ml) vial. prepare the stoppers on both parts by using sterile alcohol wipes. - peel open a bss plus vacuum transfer device package (supplied) and remove the sterile transfer spike. note: this device is vented permitting air to enter vial during solution transfer, thereby preventing the creation of a vacuum inside the vial. an air-inlet filter is provided to protect the system. do not remove the air-inlet filter. - remove protector from the white plastic piercing pin. - firmly grasp device from behind the flange and insert the white plastic piercing pin into the upright rubber stopper of the bss plus part ii (20 ml) vial. - remove guard from filter needle. firmly grasp vial in the palm of one hand and with thumb and index finger, hold plastic flange against top of vial. - invert vial and immediately insert filter needle into the outer target of the rubber stopper of the bss plus part i (480 ml) bottle. (see illustration.) - fluid will automatically transfer from the vial into the large vacuum bottle unless filter becomes occluded or loss of vacuum occurs. note: an excess amount of bss plus part ii is provided in each vial. a non-transferred solution residual of approximately 0.3 ml can be expected to remain in the vial. - immediately remove needle from the bss plus part i container and discard it after solution transfer has been completed. - place a sterile safety cap over the rubber stopper of part i if the solution is not going to be used immediately. mix the solution gently until uniform. peel off the right-hand side of part i bottle label (fully reconstituted bss plus solution). record the patient’s name and the date and time of reconstitution. bss plus solution is now ready for use. caution: reconstituted bss plus solution must be used within six hours of mixing. discard any solution which has aged beyond that time. never use the same bottle of bss plus solution on more than one patient. alternative transfer method if preferred, the contents of the bss plus part ii component may be aspirated with an 18-gauge cannula attached to a 20 ml syringe and then transferred into the part i bottle. alcon distributed by: alcon laboratories, inc. fort worth, texas 76134 usa revised: april 2023

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - hypromellose 2910 (4000 mpa.s) (unii: rn3152op35) (hypromellose 2910 (4000 mpa.s) - unii:rn3152op35) - - for the temporary relief of burning and irritation due to dryness of the eye - for use as a protectant against further irritation - if this solution changes color or becomes cloudy if this solution changes color or becomes cloudy - if you are sensitive to any ingredient in this product you experience any of the following: - eye pain - changes in vision - continued redness or irritation - condition worsens or persists for more than 72 hours

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37), sodium citrate (unii: 1q73q2julr) (sodium cation - unii:lyr4m0nh37) - for use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - neomycin 3.5 mg in 1 g - ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus   influenzae , klebsiella /enterobacter species, neisseria species, and pseudomonas aeruginosa. this product does not provide adequate coverage against: serratia   marcescens   and streptococci, including

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - ciprofloxacin 2 mg in 1 ml - cipro® hc otic is indicated for the treatment of acute otitis externa in adult and pediatric patients, one year and older, due to susceptible strains of pseudomonas aeruginosa , staphylococcus aureus , and proteus mirabilis . cipro® hc otic is contraindicated in persons with a history of hypersensitivity to hydrocortisone, ciprofloxacin or any member of the quinolone class of antimicrobial agents. this nonsterile product should not be used if the tympanic membrane is known or suspected to be perforated. use of this product is contraindicated in viral infections of the external canal including varicella and herpes simplex infections. the safety and efficacy of cipro® hc otic have been established in pediatric patients 2 years and older (131 patients) in adequate and well-controlled clinical trials. efficacy has been extrapolated for patients, age 1 year and above based on studies in adults and older pediatric patients.

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - natamycin (unii: 8o0c852cpo) (natamycin - unii:8o0c852cpo) - natacyn® (natamycin ophthalmic suspension) 5% is indicated for the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including fusarium solani keratitis. as in other forms of suppurative keratitis, initial and sustained therapy of fungal keratitis should be determined by the clinical diagnosis, laboratory diagnosis by smear and culture of corneal scrapings and drug response. whenever possible the in vitro activity of natamycin against the responsible fungus should be determined. the effectiveness of natamycin as a single agent in fungal endophthalmitis has not been established. natacyn® (natamycin ophthalmic suspension) 5% is contraindicated in individuals with a history of hypersensitivity to any of its components. safety and effectiveness in pediatric patients have not been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37), sodium citrate (unii: 1q73q2julr) (sodium cation - unii:lyr4m0nh37) - sodium chloride 6.4 mg in 1 ml - for use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - suspension/ drops - 1 mg in 1 ml - steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctuate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. contraindicated in epithelial herpes simplex (dendritic keratitis), vaccinia, varicella, and most other viral diseases of the cornea and conjunctiva; tuberculosis of the eye; fungal disease of ocular structures; and in those persons who have shown hypersensitivity to any component of this preparation.

Singapore - English - HSA (Health Sciences Authority)

alcon pte ltd - ophthalmology - for the temporary relief of burning and irritation due to dryness of the eye.

Singapore - English - HSA (Health Sciences Authority)

alcon pte ltd - ophthalmology - systane ultra lubricant eye drops is indicated for the temporary relief of burning and irritation due to dryness of the eye. systane ultra lubricant eye drops may be used to lubricate and rewet daily, extended wear and disposable silicone hydrogel and soft (hydrophilic) contact lenses. systane ultra lubricant eye drops moistens your contact lenses, reduces discomfort with contact lens wear, and helps to remove particulate material that may cause irritation and/or discomfort.